Aims: to educate delegates on benefits of next generation sequencing (NGS) genotyping to identify rare variants for NHS-reimbursed therapies, compassionate use programmes and trials enrolment. All data will pertain to advanced NSCLC.

Chair: Professor Sanjay Popat 17:30 Introduction Sanjay Popat 17:31 BRAF, KRAS, & insertion mutations you need to know about Raffaele Califano 17:46 Splices and fusions you need to know about Alastair Greystoke 18:01 How will we find suitable patients? Rachel Butler 18:16 Q&A

18:30 Close